HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro and in vivo efficacy of PEGylated diisopropyl fluorophosphatase (DFPase).

Abstract
Highly toxic organophosphorus compounds that irreversibly inhibit the enzyme acetycholinesterase (AChE), including nerve agents like tabun, sarin, or soman, still pose a credible threat to civilian populations and military personnel. New therapeutics that can be used as a pretreatment or after poisoning with these compounds, complementing existing treatment schemes such as the use of atropine and AChE reactivating oximes, are currently the subject of intense research. A prominent role among potential candidates is taken by enzymes that can detoxify nerve agents by hydrolysis. Diisopropyl fluorophosphatase (DFPase) from the squid Loligo vulgaris is known to effectively hydrolyze DFP and the range of G-type nerve agents including sarin and soman. In the present work, DFPase was PEGylated to increase biological half-life, and to lower or avoid an immunogenic reaction and proteolytic digest. Addition of linear polyethylene glycol (PEG) chains was achieved using mPEG-NHS esters and conjugates were characterized by electrospray ionization--time of flight--mass specrometry (ESI-ToF-MS). PEGylated wildtype DFPase and a mutant selective for the more toxic stereoisomers of the agents were tested in vivo with rats that were challenged with a subcutaneous 3x LD(50) dose of soman. While wildtype DFPase prevented death only at extremely high doses, the mutant was able keep the animals alive and to minimize or totally avoid symptoms of poisoning. The results serve as a proof of principle that engineered variants of DFPase are potential candidates for in vivo use if substrate affinity can be improved or the turnover rate enhanced to lower the required enzyme dose.
AuthorsMarco Melzer, Anne Heidenreich, Frederic Dorandeu, Jürgen Gäb, Kai Kehe, Horst Thiermann, Thomas Letzel, Marc-Michael Blum
JournalDrug testing and analysis (Drug Test Anal) 2012 Mar-Apr Vol. 4 Issue 3-4 Pg. 262-70 ISSN: 1942-7611 [Electronic] England
PMID22174192 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2011 John Wiley & Sons, Ltd.
Chemical References
  • Antidotes
  • Chemical Warfare Agents
  • Cholinesterase Inhibitors
  • Polyethylene Glycols
  • Soman
  • Phosphoric Triester Hydrolases
  • diisopropyl-fluorophosphatase
Topics
  • Animals
  • Antidotes (chemistry, therapeutic use)
  • Chemical Warfare Agents (poisoning)
  • Cholinesterase Inhibitors (poisoning)
  • Loligo (enzymology, genetics)
  • Male
  • Mass Spectrometry
  • Mutation
  • Phosphoric Triester Hydrolases (chemistry, genetics, therapeutic use)
  • Polyethylene Glycols (chemistry)
  • Rats
  • Rats, Wistar
  • Soman (poisoning)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: